Mitomycin	mitomycin	O	O	OTHERS	I
C	c	O	O	OTHERS	I
associated	associated	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
uremic	uremic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Mitomycin	mitomycin	O	O	OTHERS	I
C	c	O	O	OTHERS	I
associated	associated	O	O	O	O
Hemolytic	hemolytic	O	DISEASE	OTHERS	I
Uremic	uremic	O	DISEASE	OTHERS	I
Syndrome	syndrome	O	DISEASE	OTHERS	I
(	(	O	O	O	O
HUS	hus	O	DISEASE	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
potentially	potentially	O	O	O	O
fatal	fatal	O	O	O	O
but	but	O	O	O	O
uncommon	uncommon	O	O	O	O
condition	condition	O	O	O	O
that	that	O	O	O	O
is	is	O	O	O	O
not	not	O	O	O	O
yet	yet	O	O	O	O
widely	widely	O	O	O	O
recognised	recognised	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
consists	consists	O	O	O	O
of	of	O	O	O	O
microangiopathic	microangiopathic	O	O	OTHERS	I
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
progressive	progressive	O	O	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
mitomycin	mitomycin	O	O	OTHERS	I
C	c	O	O	OTHERS	I
treatment	treatment	O	O	O	O
and	and	O	O	O	O
affects	affects	O	O	O	O
about	about	O	O	O	O
10	10	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
this	this	O	O	O	O
agent	agent	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
usually	usually	O	O	O	O
develops	develops	O	O	O	O
about	about	O	O	O	O
8	8	O	O	O	O
-	-	O	O	O	O
10	10	O	O	O	O
mth	mth	O	O	O	O
after	after	O	O	O	O
start	start	O	O	O	O
of	of	O	O	O	O
mitomycin	mitomycin	O	O	OTHERS	I
C	c	O	O	OTHERS	I
treatment	treatment	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
mortality	mortality	O	O	O	O
is	is	O	O	O	O
approximately	approximately	O	O	O	O
60	60	O	O	O	O
%	%	O	O	O	O
from	from	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
or	or	O	O	O	O
pulmonary	pulmonary	O	DISEASE	OTHERS	I
edema	edema	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Renal	renal	O	O	OTHERS	I
lesions	lesions	O	O	OTHERS	I
are	are	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
those	those	O	O	O	O
seen	seen	O	O	O	O
in	in	O	O	O	O
idiopathic	idiopathic	O	O	O	O
HUS	hus	O	DISEASE	OTHERS	I
and	and	O	O	O	O
include	include	O	O	O	O
arteriolar	arteriolar	O	O	O	O
fibrin	fibrin	O	O	O	O
thrombi	thrombi	O	DISEASE	OTHERS	I
,	,	O	O	O	O
expanded	expanded	O	O	O	O
subendothelial	subendothelial	O	O	O	O
zones	zones	O	O	O	O
in	in	O	O	O	O
glomerular	glomerular	O	O	O	O
capillary	capillary	O	O	O	O
walls	walls	O	O	O	O
,	,	O	O	O	O
ischemic	ischemic	O	O	OTHERS	I
wrinkling	wrinkling	O	O	O	O
of	of	O	O	O	O
glomerular	glomerular	O	O	O	O
basement	basement	O	O	O	O
membranes	membranes	O	O	O	O
and	and	O	O	O	O
mesangiolysis	mesangiolysis	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
mechanism	mechanism	O	O	O	O
of	of	O	O	O	O
action	action	O	O	O	O
is	is	O	O	O	O
postulated	postulated	O	O	O	O
as	as	O	O	O	O
mitomycin	mitomycin	O	O	O	O
C-induced	c-induced	O	O	O	O
endothelial	endothelial	O	O	O	O
cell	cell	O	O	O	O
damage	damage	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
describe	describe	O	O	O	O
the	the	O	O	O	O
clinical	clinical	O	O	O	O
course	course	O	O	O	O
and	and	O	O	O	O
pathological	pathological	O	O	O	O
findings	findings	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
65	65	O	O	O	O
yr-old	yr-old	O	O	O	O
man	man	O	O	O	O
with	with	O	O	O	O
gastric	gastric	O	O	OTHERS	I
adenocarcinoma	adenocarcinoma	O	O	OTHERS	I
who	who	O	O	O	O
developed	developed	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
and	and	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
while	while	O	O	O	O
on	on	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
mitomycin	mitomycin	O	O	OTHERS	I
C	c	O	O	OTHERS	I
and	and	O	O	O	O
died	died	O	O	O	O
in	in	O	O	O	O
pulmonary	pulmonary	O	DISEASE	OTHERS	I
edema	edema	O	DISEASE	OTHERS	I
.	.	O	O	O	O

